Open AccessAcute radiation pneumonitis after conformational radiotherapy for nonsmall cell lung cancer: Clinical, dosimetric, and associated-treatment risk factors
Author(s) -
Étienne Giroux Leprieur,
D. Fernandez,
Gilles Châtellier,
Susanne Klotz,
P. Giraud,
C. Durdux
Publication year - 2013
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.119339
Subject(s) - medicine , radiation therapy , gemcitabine , univariate analysis , lung cancer , pneumonitis , odds ratio , concomitant , induction chemotherapy , chemotherapy , oncology , confidence interval , complication , lung , gastroenterology , multivariate analysis
Conformational thoracic radiotherapy (CTR) is a key-treatment in locally advanced nonsmall cell lung cancer (LA-NSCLC). Acute radiation pneumonitis (ARP) is one of the major complications.